Friess Associates LLC Zoetis Inc. Transaction History

Friess Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$157.07 - $174.35 $18.3 Million - $20.4 Million	-116,779 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$111.92 - $142.53 $1.2 Million - $1.52 Million	-10,698 Reduced 8.39%	116,779 $16 Million
Q1 2020 May 15, 2020	BUY	$92.66 - $144.94 $11.8 Million - $18.5 Million	127,477 New	127,477 $15 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $25.9 Million - $29 Million	-310,643 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $10,387 - $11,596	-130 Reduced 0.04%	310,643 $26.5 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $8,366 - $9,908	-117 Reduced 0.04%	310,773 $26 Million
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $44,268 - $50,960	700 Added 0.23%	310,890 $22.4 Million
Q3 2017 Nov 14, 2017	BUY	$59.73 - $65.4 $18.5 Million - $20.3 Million	310,190	310,190 $19.8 Million

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.